Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01113593 · ClinicalTrials.gov registry record · Phase 2
A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease
A Phase 2 study, sponsored by Dey.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT01113593 is a Phase 2 study that has completed, run by Dey. The registered enrollment target is 45 participants.
The verdict
NCT01113593, a Phase 2 study, has completed, sponsored by Dey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the pharmacodynamic profile of Formoterol Fumarate and Foradil Aerolizer
Interventions
- DRUG Formoterol Fumarate
- DRUG Foradil Aerolizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01113593
The ClinicalTrials.gov registry entry for NCT01113593 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dey, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Formoterol Fumarate is the first listed.
NCT01113593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01113593 about?
NCT01113593 is a clinical study titled "A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease". The purpose of this study is to characterize the pharmacodynamic profile of Formoterol Fumarate and Foradil Aerolizer
What is the current status of trial NCT01113593?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2010-05.
What interventions are being tested in trial NCT01113593?
The interventions under investigation include: Formoterol Fumarate (DRUG), Foradil Aerolizer (DRUG).
Who is sponsoring clinical trial NCT01113593?
This trial is sponsored by Dey, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.